Suchergebnis | Hamburg Open Science

Facetten

23 Einträge gefunden

Cetuximab enhances the efficacy of bortezomib in squamous cell carcinoma cell lines.
2009 - Forschungsinformationssystem des UKE
Effect of bortezomib on EGFR expression in head and neck squamous cell carcinoma cell lines.
2008 - Forschungsinformationssystem des UKE
Antiproliferative activity of bortezomib alone and in combination with cisplatin or docetaxel in head and neck squamous cell carcinoma cell lines.
2008 - Forschungsinformationssystem des UKE
Effects of combination treatment of bortezomib and dexamethasone in SCCHN cell lines depend on tumor cell specificity.
2008 - Forschungsinformationssystem des UKE
Effect of bortezomib and cetuximab in EGF-stimulated HNSCC.
2008 - Forschungsinformationssystem des UKE
Primary B cell lymphoma of the sphenoid sinus: CT and MRI characteristics with correlation to perfusion and spectroscopic imaging features.
2007 - Forschungsinformationssystem des UKE
Iron oxide particle-enhanced magnetic resonance imaging for detection of benign lymph nodes in the head and neck: how reliable are the results?
2007 - Forschungsinformationssystem des UKE
In vivo proton MR spectroscopy of primary tumours, nodal and recurrent disease of the extracranial head and neck.
2007 - Forschungsinformationssystem des UKE
Usefulness of MRI volumetric evaluation in patients with squamous cell cancer of the head and neck treated with neoadjuvant chemotherapy.
2007 - Forschungsinformationssystem des UKE
Inverse correlation between serum PGE2 and T classification in head and neck cancer.
2007 - Forschungsinformationssystem des UKE
Quantitative measurements of perfusion and permeability of oropharyngeal and oral cavity cancer, recurrent disease, and associated lymph nodes using first-pass contrast-enhanced computed tomography studies.
2007 - Forschungsinformationssystem des UKE
Demands on caring relatives of head and neck cancer patients.
2007 - Forschungsinformationssystem des UKE
Enhancement of docetaxel efficacy in head and neck cancer treatment by G0 cell stimulation.
2007 - Forschungsinformationssystem des UKE
Prestimulation of head and neck cancer cells with growth factors enhances treatment efficacy.
2006 - Forschungsinformationssystem des UKE
A phase II trial of docetaxel, cisplatin and 5-fluorouracil in patients with recurrent squamous cell carcinoma of the head and neck (SCCHN).
2006 - Forschungsinformationssystem des UKE
Adjuvant docetaxel, cisplatin and 5-fluorouracil (TPF) in locally advanced squamous cell carcinoma of the head and neck.
2006 - Forschungsinformationssystem des UKE
AdOnco: a database for clinical and scientific documentation of head and neck oncology.
2006 - Forschungsinformationssystem des UKE
The efficacy of MRI with ultrasmall superparamagnetic iron oxide particles (USPIO) in head and neck cancers.
2005 - Forschungsinformationssystem des UKE
EGFR-antibody-supplemented TPF chemotherapy. Preclinical investigations to a novel approach for head and neck cancer induction treatment.
2005 - Forschungsinformationssystem des UKE
Iressa (ZD 1839) inhibits phosphorylation of three different downstream signal transducers in head and neck cancer (SCCHN).
2005 - Forschungsinformationssystem des UKE

Aktive Facetten

Facetten

Zugriff

Einrichtung

Medientyp

Karte

Erscheinungsjahr

Autor/in

Sprache

Cetuximab enhances the efficacy of bortezomib in squamous cell carcinoma cell lines.

Effect of bortezomib on EGFR expression in head and neck squamous cell carcinoma cell lines.

Antiproliferative activity of bortezomib alone and in combination with cisplatin or docetaxel in head and neck squamous cell carcinoma cell lines.

Effects of combination treatment of bortezomib and dexamethasone in SCCHN cell lines depend on tumor cell specificity.

Effect of bortezomib and cetuximab in EGF-stimulated HNSCC.

Primary B cell lymphoma of the sphenoid sinus: CT and MRI characteristics with correlation to perfusion and spectroscopic imaging features.

Iron oxide particle-enhanced magnetic resonance imaging for detection of benign lymph nodes in the head and neck: how reliable are the results?

In vivo proton MR spectroscopy of primary tumours, nodal and recurrent disease of the extracranial head and neck.

Usefulness of MRI volumetric evaluation in patients with squamous cell cancer of the head and neck treated with neoadjuvant chemotherapy.

Inverse correlation between serum PGE2 and T classification in head and neck cancer.

Quantitative measurements of perfusion and permeability of oropharyngeal and oral cavity cancer, recurrent disease, and associated lymph nodes using first-pass contrast-enhanced computed tomography studies.

Demands on caring relatives of head and neck cancer patients.

Enhancement of docetaxel efficacy in head and neck cancer treatment by G0 cell stimulation.

Prestimulation of head and neck cancer cells with growth factors enhances treatment efficacy.

A phase II trial of docetaxel, cisplatin and 5-fluorouracil in patients with recurrent squamous cell carcinoma of the head and neck (SCCHN).

Adjuvant docetaxel, cisplatin and 5-fluorouracil (TPF) in locally advanced squamous cell carcinoma of the head and neck.

AdOnco: a database for clinical and scientific documentation of head and neck oncology.

The efficacy of MRI with ultrasmall superparamagnetic iron oxide particles (USPIO) in head and neck cancers.

EGFR-antibody-supplemented TPF chemotherapy. Preclinical investigations to a novel approach for head and neck cancer induction treatment.

Iressa (ZD 1839) inhibits phosphorylation of three different downstream signal transducers in head and neck cancer (SCCHN).